All Articles on Vaccine
Janssen phase 3 COVID-19 vaccine trial to begin at KPWHRIThe institute is participating in NIAID tests of Moderna and Johnson & Johnson vaccines.
COVID-19 vaccine generates immune response in older adultsThe investigational mRNA vaccine is also well tolerated, according to trial led by Kaiser Permanente Washington researcher and others.
Vaccine hesitancy in the time of COVID-19Can lessons from Immunity Community help build acceptance of COVID-19 vaccines? Clarissa Hsu, PhD, thinks so.
Flu shot Q & A: Does COVID-19 change our approach?KPWHRI’s Michael L. Jackson, PhD, MPH, talks about influenza vaccine research in the age of the pandemic.
COVID-19 vaccine well tolerated, generates immune responseNational Institute of Allergy and Infectious Diseases-sponsored phase 1 trial tested mRNA vaccine.
5 questions with an influenza and COVID-19 epidemiologistDr. Mike Jackson has long studied the spread of flu and effectiveness of vaccination at Kaiser Permanente Washington. And now… of COVID-19 too.
Coronavirus vaccine trial now includes older peopleLed by Dr. Lisa A. Jackson, first-ever trial of any experimental vaccine candidate for COVID-19 virus has expanded.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.